 | Up a level |
Journal Article
Buehler, A., Wendtner, C-M, Kipps, T. J., Rassenti, L., Fraser, G. A. M., Michallet, A-S, Hillmen, P., Duerig, J., Gregory, S. A., Kalaycio, M., Aurran-Schleinitz, T., Trentin, L., Gribben, J. G., Chanan-Khan, A., Purse, B., Zhang, J., De Bedout, S., Mei, J., Hallek, M. and Stilgenbauer, S. (2016). Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial. Blood Cancer J., 6. LONDON: NATURE PUBLISHING GROUP. ISSN 2044-5385
Geyer, C. E., Jr., Garber, J. E., Gelber, R. D., Yothers, G., Taboada, M., Ross, L., Rastogi, P., Cui, K., Arahmani, A., Aktan, G., Armstrong, A. C., Arnedos, M., Balmana, J., Bergh, J., Bliss, J., Delaloge, S., Domchek, S. M., Eisen, A., Elsafy, F., Fein, L. E., Fielding, A., Ford, J. M., Friedman, S., Gelmon, K. A., Gianni, L., Gnant, M., Hollingsworth, S. J., Im, S-A, Jager, A., Lakhani, S. R., Janni, W., Linderholm, B., Liu, T-W, Loman, N., Korde, L., Loibl, S., Lucas, P. C., Marme, F., de Duenas, E. Martinez, McConnell, R., Phillips, K-A, Piccart, M., Rossi, G., Schmutzler, R., Senkus, E., Shao, Z., Sharma, P., Singer, C. F., Spanic, T., Stickeler, E., Toi, M., Traina, T. A., Viale, G., Zoppoli, G., Park, Y. H., Yerushalmi, R., Yang, H., Pang, D., Jung, K. H., Mailliez, A., Fan, Z., Tennevet, I, Zhang, J., Nagy, T., Sonke, G. S., Sun, Q., Parton, M., Colleoni, M. A., Schmidt, M., Brufsky, A. M., Razaq, W., Kaufman, B., Cameron, D., Campbell, C., Tutt, A. N. J. and Johannsson, O. Th (2022). Overall survival in the OlympiA phase Ill trial of adjuvant olaparib in patients with germime pathogenic variants in BRCA1/2 and high-risk, early breast cancer. Ann. Oncol., 33 (12). S. 1250 - 1269. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Kelly, R. J., Ajani, J. A., Kuzdzal, J., Zander, T., Van Cutsem, E., Piessen, G., Mendez, G., Feliciano, J. L., Motoyama, S., Lievre, A., Uronis, H., Elimova, E., Grootscholten, C., Geboes, K., Zhang, J., Zhu, L., Lei, M., Kondo, K., Cleary, J. M. and Moehler, M. (2020). Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiation therapy (CRT): First results of the CheckMate 577 study. Ann. Oncol., 31. S. S1193 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Li, G., Zhang, J., Herrmann, H. J., Shao, Y. and Huang, N. (2020). Study of Aerodynamic Grain Entrainment in Aeolian Transport. Geophys. Res. Lett., 47 (11). WASHINGTON: AMER GEOPHYSICAL UNION. ISSN 1944-8007
Moehler, M., Ajani, J. A., Kuzdzal, J., Zander, T., Van Cutsem, E., Piessen, G., Mendez, G., Feliciano, J., Motoyama, S., Lievre, A., Uronis, H., Elimova, E., Grootscholten, C., Geboes, K., Zhang, J., Soleymani, S., Lei, M., Kondo, K., Cleary, J. and Kelly, R. J. (2021). Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): 14-month follow-up of CheckMate 577. Ann. Oncol., 32. S. S1045 - 3. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Oki, Y., Buglio, D., Zhang, J., Ying, Y., Zhou, S., Sureda, A., Ben-Yehuda, D., Zinzani, P. L., Prince, H. M., Harrison, S. J., Kirschbaum, M., Johnston, P. B., Shen, A., von Tresckow, B. and Younes, A. (2014). Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression. Blood Cancer J., 4. LONDON: NATURE PUBLISHING GROUP. ISSN 2044-5385
Zhang, J., Mehner, W., Holl, S., Boltes, M., Andresen, E., Schadschneider, A. and Seyfried, A. (2014). Universal flow-density relation of single-file bicycle, pedestrian and car motion. Phys. Lett. A, 378 (44). S. 3274 - 3278. AMSTERDAM: ELSEVIER. ISSN 1873-2429
Zhang, J. and Shao, Y. (2014). A new parameterization of particle dry deposition over rough surfaces. Atmos. Chem. Phys., 14 (22). S. 12429 - 12441. GOTTINGEN: COPERNICUS GESELLSCHAFT MBH. ISSN 1680-7324
Zhang, J., Shao, Y. and Huang, N. (2014). Measurements of dust deposition velocity in a wind-tunnel experiment. Atmos. Chem. Phys., 14 (17). S. 8869 - 8883. GOTTINGEN: COPERNICUS GESELLSCHAFT MBH. ISSN 1680-7324